Why we do what we do 

Posted on

At the Brain, Language and Behaviour (BLB) Lab, we are a group of researchers and clinicians united by one common goal: improving the quality of life of brain tumour patients. Based at the University of the West of England, the BLB Lab was born out of Anna Piasecki and Neil Barua’s vision to create a team and space for interdisciplinary and evidence-based translational research. 

Translational research focuses on turning scientific discoveries into practical applications that improve human health and wellbeing, aimed at real-world application in (for us) clinical settings. In the context of language and cognitive mapping in awake brain surgery, our team works towards the development of novel tasks and interventions, that clinicians can use to assess and preserve their patients’ language and communication skills. 

The starting point: brain tumour treatment 

In the UK only, 34 people are diagnosed daily with a primary brain cancer (Cancer Research UK). This number does not include diagnoses of secondary brain cancer or non-cancerous tumours, such as low-grade gliomas, which can adversely affect survivors’ quality of life.  

There can be many devastating consequences of living with a brain tumour. For instance, some people may develop language and cognitive impairments, which can lead to difficulties participating in work or social and familial life. Feelings of exclusion and depression are also common among this patient group, as is a reduced life expectancy. These all can lead to an impoverished quality of life. 

While treatment for brain tumours is increasingly more effective, the gold standard surgical technique for tumour removal is awake brain surgery (craniotomy, in medical terms), along with adjuvant therapies, such as radio- or chemotherapy. 

Fig. 1 Awake brain surgery setting in the operating room. The patient is woken from anaesthesia and performs language tests, such as naming the picture of the kangaroo, while the neurosurgeon stimulates the brain.

During an awake craniotomy (see Fig. 1), the patient is woken from sedation to complete several motor, cognitive and language tasks while the neurosurgeon stimulates the brain with direct electrical stimulation. This process guides the mapping of key brain areas for motor, cognitive and language skills, separating those areas from cancerous brain tissue to be cut out. In this way, the tumour can be removed as much as possible, while preserving brain areas that are fundamental to a person’s ability to speak, think, move, and interact with others.

A brief history of language testing in awake craniotomy

Awake language mapping has been performed for nearly a century (Fig. 2 below), starting as early as the late 1920s with Wilder Penfield pioneering cortical stimulation and evolving through the 1980s, when George Ojemann refined language mapping methods. 

Fig. 2 Timeline of developments in awake brain surgery throughout the last century.

In the last two decades, neuroimaging techniques (functional magnetic resonance imaging, fMRI, and, diffusor tensor imaging, DTI) and technological advances (virtual and augmented reality) have offered more precise insights into brain structure and function. Similarly, the tasks used for language and cognitive mapping – starting historically with simply counting from 1 to 10 or reciting the months of the year – have also (thankfully!) evolved. How many of us count to ten on a daily basis; unless, of course, you’re an accountant? Nowadays, several language skills are being tested, for example naming pictures of objects and actions, completing sentences, producing sounds, and many more. But there is still a lot to do – and that’s how our work fits in!

Awake brain surgery worldwide and in the UK

You may be wondering, what brain tumour treatment is available where you live in the UK, or rather across the different NHS Trusts? Well, we had the same question and thought it would be important for our work to know the current status quo of language testing practices in this country, especially given the diverse range of practices across the world that have been reported in recent years. For this purpose, we launched a national survey to clinical practitioners working with brain tumour patients in the UK, asking about their approach to language testing, the challenges they face, and if there were any aspects of patient care that would need improvement (click on the picture below to read the paper).

Click the paper header to read the open access article, from Neuro-Oncology Practice.

The results highlighted that language testing practices in awake craniotomy vary across the country, with clinicians advocating for more updated and comprehensive tasks to test patients with diverse linguistic skills and languages, such as bilingual patients, sign language users, and people who communicate with impaired speech and language. Equally, clinicians in the UK were calling for a more joined up approach across the Trusts and practices, as well as quicker and better support for patients after their surgery. And these are exactly the things we have started and continue to address, as you can see across the different posts in our blog. 

If you ever had an idea you wanted to pursue, make a comment about our work, or if you wanted to join our mission or research team, do get in touch (BLB.Lab@uwe.ac.uk)!

When translational work meets academic circles: Our impressions from the world’s leading conference on bilingualism  

Posted on

Earlier this month, a few members of the BLB Lab flew to Spain for the International Symposium on Bilingualism (ISB15). Anna, Sonia and Lydia were honoured to join forces with Anna Gasa Roqué, their collaborator from the Bellvitge University Hospital in Barcelona, and present a four-part symposium entitled “The unexplored power of translational research: Applying insights from awake brain surgery to our current understanding of the bilingual mind”.

To give you some context, ISB15 is a biennal conference that has grown to be the most significant event in the field of bilingualism. This year it focused on multidisciplinary research output from a range of fields, including linguistics, neuroscience, and psychology, which lie at the core of the BLB Lab research. What’s more, the conference took place in beautiful Donostia-San Sebastián, at the heart of the Spanish Basque Country, where the bilingual heritage is alive across all aspects of society.  

The symposium presenters: Anna Piasecki, Anna Gasa Roqué, Sonia Mariotti and Lydia Wiernik.

The BLB-organised symposium on translational research offered a deep dive into the fascinating world of intraoperative language testing and management of bilingual brain tumour patients. Designed to guide attendees through this complex field, the symposium began with Anna Piasecki providing a comprehensive introduction to the procedure and laying the groundwork with essential concepts and terminology. From there, the presentations gradually zoomed in, taking the audience on a journey that span from bilingualism’s role in shaping the brain to the challenges of preserving language skills of bilingual patients.

After the introduction, Anna Gasa-Roqué explored the effects of bilingualism in brain tumour patients, showing how being bilingual changes both the structure and functionality of the brain. Sonia Mariotti then focused on the important role of cognitive flexibility involved in switching between languages, and how this ability should be preserved in bilingual brain tumour patients. Finally, the symposium ended with Lydia Wiernik, who presented a compelling case study on bimodal bilingualism, showing that both spoken English and British Sign Language can be tested and preserved during awake surgery. 

Each presentation built on the last, creating a layered and immersive experience that reflected the depth and diversity of research in this area. Feedback from the audience resonated with this aspect, and fellow academics expressed genuine enthusiasm for the symposium, describing it as both intellectually enriching and clinically vital. Many highlighted the lab’s work as not only fascinating but also deeply important – pushing the boundaries of what we understand about the bilingual brain.

Presenting at ISB15 was an incredible opportunity to share the BLB Lab research with the intenational academic community. We hope that our perspective on translational research inspires more interdisciplinary collaboration between linguists, neuroscientists, and clinicians to improve intraoperative care for everyone. 

View of Donostia-San Sebastián from Monte Igueldo

Exploring the frontiers of awake brain surgery: Highlights from the 2025 Awake Craniotomy Symposium at UWE

Posted on

Today, our Brain, Language and Behaviour (BLB) Lab played host to a landmark event in the field of brain tumour surgery: the 2025 Awake Craniotomy Symposium. Organised in collaboration with the North Bristol NHS Trust and the Tessa Jowell Brain Cancer Mission, the symposium brought together a community of more than a hundred neurosurgeons, speech and language therapists, neuropsychologists, physiotherapists, anaesthetists, and researchers to explore the latest advancements and challenges in awake brain surgery. Scroll down to see the photo gallery from the event!

The day began with a warm welcome from organisers, and our BLB Lab’s co-leads, Anna Piasecki and Neil Barua, setting the tone for a programme rich in interdisciplinary insight and clinical innovation. The first session focused on preoperative planning, featuring talks on cutting-edge techniques such as Navigated Transcranial Magnetic Stimulation (nTMS) by Jose Pedro Lavrador, and Diffusion Tensor Imaging (DTI) by Puneet Plaha and Natalie Voets. Neil Barua also introduced the role of mixed reality in surgical planning, highlighting how immersive technologies can support surgical approaches with the whole multidisciplinary team’s involvement. All attendees were then invited to explore some of these technologies for themselves at the featured sponsor stands throughout the day, including wearing VR goggles, which created a high level of interest and excitement.

Session two shifted the spotlight to intraoperative test selection. Hajira Mumtaz presented the first outcome of her research at the BLB Lab: the world’s first standardised and clinically tested resource for English-language object and action naming testing, freely available to clinicians (gain access to our BOATIM material here). This was followed by a compelling trio of perspectives on cognitive and sensorimotor testing during surgery—from physiotherapy, neuropsychology, and neurosurgery—delivered by Charly Moran, Margaret Newson, and Francesco Vergani respectively. Their insights underscored each discipline’s contribution in preserving complex brain functions during the surgery.

Following the morning sessions, clinical teams from across the UK and international delegates presented some of their innovative practice over joint lunch-poster session conversations. The winning poster was collectively decided by the symposium delegates and was awarded to the clinical team from the North Midlands and North Staffordshire Combined Healthcare Trust, sharing an evaluation of their originally designed Awake Craniotomy Video Leaflet for patients.

After lunch, the afternoon resumed with Sonia Mariotti and Clare Toner, who provided an overview of clinician and patient experience of awake brain surgery practices in the UK (see here and here for their respective work), setting the scene for two subsequent panel discussions. These two interactive sessions involved the attendees in a lively conversation with a multidisciplinary panel of experts, discussing the need for consensus on test selection and follow-up protocols. The conversations revealed both the diversity of current practices across the UK and a shared desire for more unified approaches to patient care and research.

The final session, “Directions for Networking and Collaboration,” featured a series of flash talks that showcased innovative projects and case studies. Highlights included Aimun Jamjoom’s introduction of Map-OR, a digital platform for intraoperative language testing, and Sonia Mariotti’s exploration of bilingual patient testing. Tom Williamson presented on the challenges of testing multiple linguistic modalities, while Will Singleton addressed the unique considerations of awake craniotomy in paediatric patients.

The symposium concluded with reflective feedback and closing remarks, followed by a well-earned dinner at PepeNero, where conversations continued informally among colleagues and new collaborators.

The 2025 Awake Craniotomy Symposium was more than a meeting of minds—it was a celebration of the collaborative spirit that drives progress in brain surgery and cognitive science. By bridging clinical practice with research and technology, the event highlighted the importance of interdisciplinary dialogue in improving patient care and advancing our understanding of the brain. And the overwhelmingly positive feedback from delegates reaffirmed just that – followed by requests for further iterations of our symposium that helps bringing this key community together. So, watch this space!

Photo Gallery

How global citizenship enhances healthcare: Lessons from our Lab

Posted on

Immigration and global citizenship are topics that often dominate political debates, but they can sometimes leave individuals feeling unwelcome in countries they call home. Despite this, the contributions of a global workforce are indispensable, especially in sectors like healthcare, where the absence of diverse talents can put further pressure on healthcare teams. This post explores how an NHS with a global citizenship can make a real difference—both for individuals and for the communities they serve.


The value of linguistic diversity in healthcare

One key benefit of a multicultural healthcare staff is linguistic diversity. Linguistic diversity among professionals can be critical, particularly when supporting patients whose first language is not English.

This became particularly evident for us when our lab conducted a study on the practices of awake brain surgeries across the UK, encompassing England, Scotland, Wales, and Northern Ireland. A key finding was that a fair proportion of brain cancer patients were speakers of languages other than English. Among them, Polish speakers represented the largest group—a reflection of the most recent national census data. 

In awake brain surgeries, the effects of the surgical procedure on a patient’s language facilities needs to be constantly monitored. However, without a diverse workforce, this can be a challenge. Additionally, with many of the language testing mechanisms only available in English, patients may be done a disservice (see our previous post on Bilingualism).

A case study of linguistic diversity in action in the healthcare sector

What is needed are tailored testing materials and, where possible, a multilingual healthcare sector to guide staff on how to interpret patients’ responses during awake brain surgeries accurately. A recent case brought this reality close to home for our lab. Anna, the academic lead of our team, has not only helped developing comprehensive linguistic testing resources for brain cancer patients but also brought her own global citizen identity to the forefront. As a native speaker of both German and Polish, and with an honorary contract with the North Bristol NHS Trust, Anna was uniquely positioned to assist with language testing when a Polish-speaking patient required bespoke support during an awake brain surgery. Her ability to bridge linguistic and cultural gaps ensured that the surgery could proceed smoothly, demonstrating the tangible benefits of a global perspective in healthcare.

The broader impact of global perspectives

Anna’s story is just one example of how global citizenship can transform healthcare delivery. It highlights the importance of recognising and leveraging the skills that individuals from diverse backgrounds bring to critical sectors. In this case, her linguistic and cultural expertise directly impacted a patient’s care, showcasing the profound advantages of having a global workforce.

For healthcare teams, embracing linguistic diversity is not just about meeting immediate needs; it’s about creating systems that support equitable and inclusive care for all patients. Whether through the development of testing materials or the involvement of language specialists, these practices underscore how global perspectives enhance patient outcomes.

Join the conversation

If you’re interested in learning more about the practices of awake brain surgeries and the innovative solutions clinical teams develop to support their patients, check our blog for the next update. Together, we can continue to celebrate the power of global citizenship in making a difference where it matters most.

Back to top